ROCHE WN29922
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy, and Safety Study of Gantenerumab in Patients With Prodromal to Mild Alzheimer’s Disease
